Aarti Pharmalabs fundamental analysis

AARTIPHARM

645.65

10.60 (1.67%)
Last updated on 2 Apr, 2026 | 15:54 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aarti Pharmalabs Fundamentals

P/E Ratio

27.39

P/B Ratio

2.8

Div. Yield

0.77

Sector P/E

60.59

Sector P/B

3.25

Sec. Div. Yield

0.59

Aarti Pharmalabs Fundamentals is currently trading with a P/E Ratio of 27.39, compared to the sector average of 60.59. Its P/B Ratio stands at 2.8, while the sector’s is 3.25. In terms of returns, the stock offers a Dividend Yield of 0.77%, which is than the sector’s 0.59%.

Aarti Pharmalabs Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Aarti Pharmalabs reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost